- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06279468
Clinical Effectiveness of Intervertebral Disc Release in Treating Lenke 5 Adolescent Idiopathic Scoliosis
Clinical Effectiveness of Intervertebral Disc Release in Treating Lenke 5 Adolescent Idiopathic Scoliosis (INDIRECT)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hypotheses To examine the clinical effectiveness of intervertebral disc release in treating Lenke 5 adolescent idiopathic scoliosis, our working hypothesis posits that participants treated with intervertebral disc release achieve a higher rate of correction for axial vertebral rotation (especially the rotation of the apex vertebrae), demonstrate improved correction rate for coronal curve, experience no additional blood loss or allogeneic transfusions, and do not experience an increase in the length of hospital stay (LOH) or adverse event (AE) rate compared to individuals treated with Ponte osteotomy.
Objectives Based on the aforementioned hypothesis, this study aims to evaluate the clinical effectiveness of intervertebral disc release in treating Lenke 5 adolescent idiopathic scoliosis. The evaluation includes assessing the efficacy of vertebral derotation and the change in Cobb angle following the correction surgery, as well as perioperative blood loss, transfusion volume/rate, length of hospital stay, and the rate of adverse events (AEs).
Study setting and investigators The trial will take place at a tertiary care teaching hospital. The study will be conducted in the wards and operating rooms of the orthopedic department, which has 200 beds, at this comprehensive hospital with a total of 2500 beds. Participants will be recruited from the outpatient clinic by one investigator and will provide their consent to the investigators. All investigators have practical experience in clinical orthopedic research projects. A single team of surgeons, who have completed a clinical fellowship in spinal surgery, will perform the surgeries.
Participants The study will enroll patients between the ages of 10 and 18, with an American Society of Anesthesiologists (ASA) physical status classification of I-II. These patients will be diagnosed with Lenke 5 type adolescent idiopathic scoliosis and will require posterior correction, internal fixation, and bone graft fusion. Enrollment in the study will be contingent upon signing a written informed consent.
Patients with a history of previous corrective surgery, or with sharp, angulated short-segmental scoliosis, and those with congenital scoliosis requiring 3-column osteotomy will be excluded. Participants who experience dura mater laceration or unexpected massive bleeding during the operation will be excluded as well.
Randomization and concealment Before commencing the study, an independent researcher with no participant contact will utilize SAS 9.4 software (SPSS Inc., Chicago, IL, USA) to generate a blocked random number table (block size = 4). This table will be used to allocate eligible participants in a 1:1 ratio to 2 groups. A group designated as the IDR group will undergo subsequent intervertebral disc release following Ponte osteotomy on the predetermined vertebral levels, whereas the PO group will solely undergo Ponte osteotomy.
Data collection and monitoring The collected data will be entered into electronic case report forms (eCRFs) through a process of double data entry and logic validation. Subsequently, the eCRFs will be uploaded to a central server. To uphold the trial's quality standards, a proficient clinical trial expert will be invited to perform audits of both the trial implementation process and data entry on a bimonthly basis. The purpose of the regular audit is to ensure adherence to the protocol and Good Clinical Practices (GCPs). The expert may review source documents to verify the accuracy of the data recorded on CRFs. During each audit, all study records from the past 2 months will be thoroughly examined to ensure the quality of the trial conduct and the consistency between the source data and the data entered in the database. This study will not include any interim analysis.
Sample size and statistical analysis This trial will recruit 132 participants (66 participants per group) to confirm the primary outcome equivalence between IDR group and PO group. According to a prior study, the correction rate of axial rotation of the apex vertebrae is 0.60±0.23. Assuming that alpha = 0.05, power = 0.95, two-sided 95% CI, and the follow-up loss = 15%, 66 participants are needed for each group. G-power software version 3.1.9 was used for calculating the sample size. The primary outcome measures the correction rate of axial vertebral derotation. The mean values and standard deviations of these outcomes will be calculated for both the intervention and control groups. To assess the differences between the two groups, independent sample t-tests or Mann-Whitney U tests will be performed. Secondary outcomes measureå such as blood loss, allogeneic transfusions, length of hospital stay (LOH), and adverse events (AEs) will also be analyzed. Continuous variables (e.g., blood loss, LOH) will be analyzed using independent sample ttests or Mann-Whitney U tests, while categorical variables (e.g., allogeneic transfusions, AEs) will be analyzed using chi-square tests or Fisher's exact tests, as appropriate. The difference between the IDR group and PO group will be reported as mean difference and lower one-sided 95% confidence interval (CI), along with a one-sided p < 0.05. Statistical analyses will be conducted using SPSS.
Dissemination plan The trial results will be submitted to an international peer-reviewed journal. Additionally, the findings will be presented at relevant national and international conferences.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Qianyu Zhuang, Professor
- Phone Number: +86 15200838996
- Email: baizhuosong@126.com
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100035
- Recruiting
- Peking Union Medical College Hospital
-
Contact:
- Qianyu Zhuang, Professor
- Phone Number: +86 15200838996
- Email: baizhuosong@126.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Between the ages of 10 and 18
- American Society of Anesthesiologists (ASA) physical statusclassification of I-II
- Lenke 5 type adolescent idiopathic scoliosis
Exclusion Criteria:
- A history of previous corrective surgery
- With sharp, angulated short-segmental scoliosis
- With congenital scoliosis requiring 3-column osteotomy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: IDR group
A group designated as the IDR group will undergo subsequent intervertebral disc release following Ponte osteotomy on the predetermined vertebral levels.
|
After standard posterior instrumentation and fusion in scoliosis cases, Ponte osteotomies are performed on vertebrae with a Nash-Moe classification of 1 degree or higher.
The intervertebral discs on the convex side of the scoliosis, situated between the vertebrae that have undergone Ponte osteotomy, will be approached and incised parallel to the intervertebral space.
The intervertebral disc and endplate cartilage were incised and separated using reamers.
Subsequently, the intervertebral space was expanded and irrigated, and the fragments of the intervertebral disc were extracted using nucleus pulposus forceps.
Impacting bone graft into the intervertebral space, thus sustaining the optimal height of intervertebral space.
Other Names:
|
Active Comparator: PO group
The PO group will solely undergo Ponte osteotomy.
|
After standard posterior instrumentation and fusion in scoliosis cases, Ponte osteotomies are performed on vertebrae with a Nash-Moe classification of 1 degree or higher.
Subsequent corrective procedures can be performed immediately following Ponte osteotomy completion.
The deformity was corrected using the bilateral rod rotation and segmental derotation technique after inserting rods.
Under fluoroscopic guidance, compression, distraction, and in situ bending maneuvers were implemented as needed.
Allograft bone material was utilized for the purpose of bone fusion
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The correction rate of axial rotation of the apex vertebrae
Time Frame: immediately before surgery and one week after the surgery
|
Axial rotation of apex vertebrae will be measured before and one week after the surgery using a novel computer-based automated measurement algorithm applied to computed tomography (CT) images.
The algorithm used is a symmetry ratio algorithm that eliminates the need for manual landmark selection.
It operates on the premise that the axis of maximum symmetry in a vertebral cross-section determines the angular orientation of the vertebra.
|
immediately before surgery and one week after the surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Lumbar curve
Time Frame: immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
the cobb angle of the lumbar curve
|
immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
UIV tilt
Time Frame: immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
the angle between the endplate of upper instrumented vertebra and the horizontal line
|
immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
C7-CSVL
Time Frame: immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
Radiographic parameters measured by CT scan: the distance between C7 vertebra and Central Sacral Vertical Line (CSVL)
|
immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
Lumbar lordosis
Time Frame: immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
the cobb angle of lumbar lordosis on sagittal plane
|
immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
SVA
Time Frame: immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
sagittal vertical axis, the distance between C7PL and CSVL
|
immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
Radiographic parameters measured by CT scan: LIV and LIV+1 translation
Time Frame: immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
the distance from the center of LIV or LIV+1 to CSVL
|
immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
LIV tilt
Time Frame: immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
the inclination in degrees of the inferior endplate relative to the horizontal
|
immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
The lowest instrumented vertebra disc angle
Time Frame: immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
the angulation in degrees between the inferior endplate of the LIV and the superior endplate of the next caudal vertebra
|
immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
Age
Time Frame: immediately before surgery
|
the age of patients
|
immediately before surgery
|
Gender
Time Frame: immediately before surgery
|
the gender of patients
|
immediately before surgery
|
Risser grade of the patients at the time of surgery
Time Frame: immediately before surgery
|
from 0 to 5, higher grades mean a worse outcome
|
immediately before surgery
|
number of fused spinal levels
Time Frame: immediately after surgery
|
number of fused spinal levels in surgery
|
immediately after surgery
|
length of operation
Time Frame: immediately after surgery
|
length of operation from incision to closure
|
immediately after surgery
|
Scoliosis Research Society-22,SRS-22 score
Time Frame: immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
from 0 to 5, higher scores mean a better outcome
|
immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
the MOS item short from health survey, SF-36 score
Time Frame: immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
from 0 to 100, higher scores mean a better outcome
|
immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
EuroQol Five Dimensions Questionnaire, EQ-5D score
Time Frame: immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
from 0 to 5, higher scores mean a better outcome
|
immediately before surgery, 1-week post surgery, 3-month, 6-month, 1-year, 2-year, and 3-year follow-up
|
Perioperative total blood loss
Time Frame: immediately after surgery
|
Record perioperative total blood loss
|
immediately after surgery
|
Visible blood loss
Time Frame: immediately after surgery
|
Record perioperative visible blood loss
|
immediately after surgery
|
Perioperative transfusion amounts
Time Frame: immediately after surgery
|
Record perioperative transfusion amounts from treatment records
|
immediately after surgery
|
Perioperative transfusion rates
Time Frame: immediately after surgery
|
Record perioperative transfusion rates from treatment records
|
immediately after surgery
|
Rate of postoperative infection
Time Frame: immediately after surgery
|
Record the incidence rate of postoperative infection
|
immediately after surgery
|
The incidence of nerve damage
Time Frame: through study completion, an average of 3 years
|
Record the incidence rate of nerve damage
|
through study completion, an average of 3 years
|
The incidence of loss of correction
Time Frame: through study completion, an average of 3 years
|
Record the incidence rate of loss of correction
|
through study completion, an average of 3 years
|
Collaborators and Investigators
Investigators
- Principal Investigator: Qianyu Zhuang, Professor, Peking Union Medical College Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- I-23PJ2232
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adolescent Idiopathic Scoliosis
-
Cairo UniversityRecruitingScoliosis Idiopathic | Adolescent Idiopathic ScoliosisEgypt
-
Medtronic Spinal and BiologicsMedical College of Wisconsin; Syntactx; Exponent, Inc.; Medical Metrics Diagnostics...Active, not recruitingAdolescent Idiopathic Scoliosis | Juvenile Idiopathic ScoliosisUnited States, Canada, United Kingdom
-
Dr. Casey Stondell, MDPacira Pharmaceuticals, IncRecruitingAdolescent Idiopathic Scoliosis | Juvenile Idiopathic ScoliosisUnited States
-
Spino Modulation Inc.TerminatedAdolescent Idiopathic Scoliosis | Juvenile Idiopathic ScoliosisCanada
-
The University of Hong KongActive, not recruitingScoliosis | Adolescent Idiopathic Scoliosis | Idiopathic ScoliosisHong Kong
-
St. Justine's HospitalModulate TechnologiesNot yet recruitingAdolescent Idiopathic Scoliosis
-
Connecticut Children's Medical CenterUniversity of ConnecticutRecruitingAdolescent Idiopathic ScoliosisUnited States
-
Lokman Hekim ÜniversitesiNot yet recruitingAdolescent Idiopathic Scoliosis
-
University of British ColumbiaNot yet recruitingAdolescent Idiopathic Scoliosis
-
Bezmialem Vakif UniversityRecruitingAdolescent Idiopathic ScoliosisTurkey
Clinical Trials on intervertebral disc release
-
St George's, University of LondonCompleted
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...RecruitingIntervertebral Disc Degeneration | Discogenic Pain | Discogenic DiseaseItaly
-
The Cleveland ClinicWithdrawn
-
SpinalMotionTerminatedDegenerative Disc DiseaseUnited States
-
Woebot HealthCompleted
-
Nova Scotia Health AuthorityZimmer BiometCompletedSpinal Stenosis | Spondylolisthesis | Degenerative Lumbar Disc DiseaseCanada
-
Tetec AGCompletedIntervertebral Disc Displacement | Intervertebral Disc DegenerationGermany, Austria
-
Aesculap Implant SystemsCompletedDegenerative Disc DiseaseUnited States
-
Woebot HealthActive, not recruiting